12/3
08:00 am
nxl
Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 SYNC™ Neurostimulation Console in Alzheimer’s Disease Program
Low
Report
Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 SYNC™ Neurostimulation Console in Alzheimer’s Disease Program
12/2
08:00 am
nxl
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4
Medium
Report
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4
11/22
02:11 am
nxl
Nexalin Technology (NASDAQ:NXL) was downgraded by analysts at
Wall Street
Medium
Report
Nexalin Technology (NASDAQ:NXL) was downgraded by analysts at
Wall Street
11/22
02:11 am
nxl
Nexalin Technology (NASDAQ:NXL) was downgraded by analysts at
Wall Street
Medium
Report
Nexalin Technology (NASDAQ:NXL) was downgraded by analysts at
Wall Street
11/18
01:18 pm
nxl
Nexalin Technology (NASDAQ:NXL) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Nexalin Technology (NASDAQ:NXL) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/18
09:00 am
nxl
Nexalin’s 15 Milliamp Neurostimulation Device Demonstrates Promising Results in Treating Gambling Disorder with Alcohol Use Comorbidity
Medium
Report
Nexalin’s 15 Milliamp Neurostimulation Device Demonstrates Promising Results in Treating Gambling Disorder with Alcohol Use Comorbidity
11/13
10:27 am
nxl
Nexalin Technology Appoints Carmi Masha Technologies Ltd. as Exclusive Distributor in Israel [Yahoo! Finance]
Medium
Report
Nexalin Technology Appoints Carmi Masha Technologies Ltd. as Exclusive Distributor in Israel [Yahoo! Finance]
11/13
09:15 am
nxl
Nexalin Technology Appoints Carmi Masha Technologies Ltd. as Exclusive Distributor in Israel
Medium
Report
Nexalin Technology Appoints Carmi Masha Technologies Ltd. as Exclusive Distributor in Israel
11/12
01:27 pm
nxl
Nexalin Technology (NASDAQ:NXL) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Nexalin Technology (NASDAQ:NXL) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/7
01:14 am
nxl
Nexalin Technology (NASDAQ:NXL) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Nexalin Technology (NASDAQ:NXL) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/5
08:30 am
nxl
Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia
High
Report
Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia
11/1
01:05 am
nxl
Nexalin Technology (NASDAQ:NXL) was upgraded by analysts at
Wall Street Z
Medium
Report
Nexalin Technology (NASDAQ:NXL) was upgraded by analysts at
Wall Street Z
10/30
08:30 am
nxl
Nexalin Technology Announces Regulatory Approval to Sell Gen 2 SYNC, 15 mA Neurostimulation DIFS™ Device in Israel
Medium
Report
Nexalin Technology Announces Regulatory Approval to Sell Gen 2 SYNC, 15 mA Neurostimulation DIFS™ Device in Israel
10/21
09:00 am
nxl
Nexalin’s DIFS™ Neurostimulation Shows Cognitive and Brain Network Improvements in Alzheimer’s and Dementia Across Three Peer-Reviewed Studies
Medium
Report
Nexalin’s DIFS™ Neurostimulation Shows Cognitive and Brain Network Improvements in Alzheimer’s and Dementia Across Three Peer-Reviewed Studies
10/17
08:10 pm
nxl
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV [Yahoo! Finance]
High
Report
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV [Yahoo! Finance]